HOME > Business Wire > Article
Nidec Announces the Status of Own Share Repurchase
(Repurchase of own shares, pursuant to the Company’s Articles of Incorporation based on the provisions of Item 1 of Article 459 (1) of the Companies Act of Japan)
KYOTO, Japan--( BUSINESS WIRE )-- Nidec Corporation (TOKYO: 6594; OTC US: NJDCY) (the “Company”) today announced the status of the Company’s own share repurchase under its ongoing repurchase plan resolved at a meeting of the Board of Directors held on July 23, 2024, pursuant to Item 1 of Article 459 (1) of the Companies Act of Japan.
Details of Share Repurchase
- Period of own share repurchase: From January 1, 2025 through January 31, 2025
- Class of shares: Common stock
- Number of own shares repurchased: 0
- Total repurchase amount: 0 yen
Note: The above repurchase information has been prepared on the basis of trade date.
Reference
A) Details of the share repurchase plan authorized by the Board of Directors on July 23, 2024:
- Class of shares: Common stock
- Total number of shares that may be repurchased: Up to 10,000,000 shares
(0.87% of total number of shares issued, excluding treasury stock) - Total repurchasable amount: 35 billion yen
- Period of repurchase: From May 27, 2024 through May 26, 2025
B) Total number and yen amount of own shares repurchased from May 27, 2024 through
January 31, 2025, pursuant to the Board of Directors resolution above:
- Total number of own shares repurchased: 0
- Total repurchase amount: 0 yen
View source version on businesswire.com: https://www.businesswire.com/news/home/20250203861797/en/
Source: Nidec Corporation
Business Wire
-
02/18 15:50 Nihon Global Growth Partners Issues Presentation Highlighting the Sign...
-
02/18 09:00 3D Investment Partners Issues Open Letter to Sapporo’s Board of Dire...
-
02/18 05:00 Kyocera to Establish "O-RU Alliance" to Advance 5G Open RAN Deployment...
-
02/18 05:00 Kyocera Develops AI-powered 5G Virtualized Base Station for the Teleco...
-
02/18 02:10 Mitsubishi Electric Researcher Elevated to IEEE Fellow, Class of 2025
-
02/17 07:01 FPT Establishes FPT BTP Park to Enhance SAP Business in Japan
-
02/17 06:40 Mitsubishi Electric Signs Agreement with HD Renewable Energy, Will Est...
-
02/15 08:18 ispace Completes Success 5 of Mission 2 Milestones
-
02/14 23:50 U.S. FDA Grants Full Approval of Deciphera’s ROMVIMZA™ (vimseltini...
-
02/14 14:25 AESC Ranks Fourth in 2024 Global Energy Storage Cell Shipments Accordi...
-
02/14 09:12 Kao Corporation Discloses the "Board of Directors' Opinion on Sharehol...
-
02/14 08:43 MUFG Bank, Ltd. announces Risk-Adjusted Capital Ratio Based on the Bas...
-
02/14 02:10 Mitsubishi Electric and CP Group Join Forces in Support of Increased S...
-
02/13 17:00 Nexon Releases Earnings for Fourth Quarter and Full-Year 2024
-
02/13 16:00 INFINITI at the 2025 Canadian International Auto Show
-
02/13 16:00 EXEO Group Selects Tonkean as Premier Process Automation and Orchestra...
-
02/13 13:36 Women Entrepreneurs from ASEAN and Japan Drive Innovation, Sustainabil...
-
02/13 12:00 Fonon Technologies to Bring Cutting-Edge Laser Tech to NCMS Sustainmen...
-
02/13 02:00 Kao: Bioré UV Partners with Stray Kids for an Exciting New Global Sun...
-
02/13 01:00 Yamaha Motor: Consolidated Business Results Summary ‐ Full Fiscal Ye...
-
02/13 00:00 Brightcove Appoints Takayuki Tadokoro As Country Manager of Brightcove...
-
02/12 12:00 SBC Medical Group Holdings Announces its Purchase of Bitcoin
-
02/12 09:57 MUFG Bank, Ltd. announces Consolidated Summary Report for the nine mon...
-
02/12 06:30 JT Group Recognized on CDP’s “Climate Change A List” For the 6th...
-
02/12 01:30 ONLYONE TRAVEL, a Pioneer in Unique Custom-Made Journeys, Raises 100 M...
-
02/11 14:05 Robotics Research: How Asia, Europe and America Invest – IFR Reports
-
02/11 14:02 LRN Research Unveils Key Gaps and Opportunities in Global Ethics and C...
-
02/11 14:00 Oracle Red Bull Racing and 1Password Upgrade Security in Multi-Year Pa...
-
02/11 11:00 Telecentro Argentina Expands Use of Netcracker Digital OSS and Critica...
-
02/10 22:00 Pfizer and Astellas’ PADCEV® (enfortumab vedotin-ejfv) plus KEYTRUD...